Valeant Raises Salix Bid, Agree To All-Cash Deal By: Benzinga via Benzinga March 16, 2015 at 08:41 AM EDT Valeant Pharmaceuticals Intl Inc (NYSE: VRX) has raised its bid for Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) to $173 per share from ... Read More >> Related Stocks: Endo Int'l Plc Macy's Valeant Pharmaceuticals International, Inc.